|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis/ m/ `5 c6 |- o6 U2 C/ k
was to close its brain research facility in Basel, Switzerland,
; q" E+ Q, c2 h8 c4 s$ Y4 Jthe story noted that this move closely followed similar cuts/ E W; M+ g: B% Q7 z
by rival pharmaceutical firms. As a report from the European College
- }; R) j( h( Bof Neuropsychopharmacology
$ W: p' _: x! Z7 I- M* _$ M/ U6 H! rhad warned a few months earlier, the, ~$ P+ k- H, }" Y
abandonment of research into new psychiatric drugs by AstraZeneca,+ O* ^$ A) ?+ M4 [: u& E' T7 w
GlaxoSmithKline
, a' L4 ~8 M& Tand others meant that “withdrawal of research
: a1 T. `0 Z: c% C2 ]resources is a withdrawal of hope for patients and their families”.
; I- O" r2 b+ J5 c
! Q# c5 |8 |1 C2 [* J/ X, E$ L& C$ e$ K/ K" y; I* ]0 i
回复有免费下载链接
- e' e8 ]# c9 j3 k3 c. J0 u1 v3 v1 L5 Q
|
-
总评分: 包包 + 20
查看全部评分
|